Latent Health builds intelligence infrastructure for American healthcare. Founded in 2023 by Sriram Somasundaram and Rishabh Jain, the company develops an Enterprise Pharmacy Intelligence platform powered by a clinical agentic engine that automates prior authorization and medication access workflows for health systems. The engine ingests data from doctor's notes, lab results and other clinical documents to surface patient evidence, parse payer policies, check medical necessity, auto-fill forms and route appeals - work that connects providers, insurers and pharmaceutical companies around specialty medication approvals. The stated effect is a reduction in the time from prescription to patient care from days to minutes.
The technical work spans several domains: clinical AI, agentic AI, natural language processing, document parsing and data extraction, workflow automation, healthcare interoperability and prior authorization automation. Teams working on the platform confront problems in extracting structured evidence from unstructured clinical text, reasoning over payer policy documents and integrating with the systems that health systems, payers and pharmacies already use.
Latent Health reports that more than 50 health systems use the platform. Among the metrics the company cites are a 109% increase in prior-authorization throughput per team member, an 85% specialty fill capture rate and over $300K in annual labour cost avoided per health system. The company has raised $80M in total, at Series A stage, from investors including Transformation Capital, Spark Capital, McKesson Ventures and Y Combinator. Its operations are concentrated in the United States, serving health systems and hospitals, specialty pharmacy, payers and the pharmaceutical industry.
The company describes its mission in terms of reducing delays in patient access to medication and freeing clinical staff to focus on patient care. It positions itself as a founder-led, venture-backed AI company scaling in healthcare.
